[Form 4] Atlassian Corp Insider Trading Activity
Rhea-AI Filing Summary
Michael Cannon-Brookes, CEO and co-founder of Atlassian Corp (TEAM) and a 10% owner, reported multiple sales of Class A common stock executed on 09/29/2025 under a Rule 10b5-1 trading plan adopted February 20, 2025. The Form 4 shows dispositions of 512, 3,532, 1,294, and 2,327 shares at weighted-average prices of $168.259, $166.2576, $167.5119, and $165.4604, respectively. Post-transactions, reported indirect beneficial ownership is 7,665 shares held by CBC Co Pty Limited as trustee for the Cannon-Brookes Head Trust.
Positive
- Trades executed under a Rule 10b5-1 trading plan, indicating pre-planned, compliant insider sales.
- Detailed execution disclosure with weighted-average prices and intra-day price ranges in footnotes enhances transparency.
- Form 4 is properly signed by an attorney-in-fact, showing procedural completeness.
Negative
- Insider sold shares (512, 3,532, 1,294, and 2,327 shares) on 09/29/2025, reducing indirect beneficial ownership.
- Indirect holdings declined to 7,665 shares held by CBC Co Pty Limited as trustee for the Cannon-Brookes Head Trust.
Insights
TL;DR Insider sales under a pre-established Rule 10b5-1 plan reduced indirect holdings; disclosure is orderly and not an unscheduled block sale.
The Form 4 documents four separate dispositions on 09/29/2025 by Michael Cannon-Brookes under a Rule 10b5-1 plan adopted February 20, 2025. Each sale lists weighted-average execution prices and the form identifies the remaining indirect holdings (7,665 shares) held via CBC Co Pty Limited as trustee. For investors, the key elements are the use of a pre-established trading plan and detailed price ranges provided in footnotes, which increase transparency about execution timing and pricing.
TL;DR Transactions were executed pursuant to a documented 10b5-1 plan, aligning with standard insider trading compliance practices.
The filing explicitly states the trades were effected under a Rule 10b5-1 plan adopted on February 20, 2025, and provides price ranges and weighted-average prices for each tranche. Beneficial ownership is held indirectly by a trustee. The filing is procedurally complete with an attorney-in-fact signature, enhancing governance transparency. No derivative transactions or amendments are reported.